![]() |
CrossRef Text and Data Mining |
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining. |
Knockdown of EMMPRIN (OX47) in MRMT-1 Carcinoma Cells Inhibits Tumor Growth and Decreases Cancer-Induced Bone Destruction and Pain |
Yanke Chen, Jing Luan, Ting Jiang, Donghui Cai, Chao Sun, Xiaofei Wang, Xiaoge Zhao, Xingchun Gou |
Cancer Research and Treatment. 2021;53(2):576-583. Published online 2020 October 29 DOI: https://doi.org/10.4143/crt.2020.801 |
Knockdown of EMMPRIN (OX47) in MRMT-1 Carcinoma Cells Inhibits Tumor Growth and Decreases Cancer-Induced Bone Destruction and Pain Sex-difference affects disease progression in the MRMT-1 model of cancer-induced bone pain Effect of sex in the MRMT-1 model of cancer-induced bone pain Effect of sex in the MRMT-1 model of cancer-induced bone pain AbobotulinumtoxinA (Dysport®) shows efficacy in a model of MRMT-1–induced bone cancer pain in the rat Knockdown of autophagy-related protein 6, Beclin-1, decreases cell growth, invasion, and metastasis and has a positive effect on chemotherapy-induced cytotoxicity in osteosarcoma cells Monoacylglycerol lipase (MAGL) knockdown inhibits tumor cells growth in colorectal cancer xCT knockdown in human breast cancer cells delays onset of cancer-induced bone pain Chondroadherin prevents bone loss and inhibits tumor growth in animal models of osteoporosis and cancer-induced bone disease KLF9, a transcription factor induced in flutamide-caused cell apoptosis, inhibits AKT activation and suppresses tumor growth of prostate cancer cells |
This metadata service is kindly provided by CrossRef from May 29, 2014. Cancer Res Treat has participated in CrossRef Text and Data Mining service since October 29, 2014. |